A new trading day began on Friday, with Compass Therapeutics Inc (NASDAQ: CMPX) stock price up 3.96% from the previous day of trading, before settling in for the closing price of $2.02. CMPX’s price has ranged from $0.76 to $4.08 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -38.89%. With a float of $87.96 million, this company’s outstanding shares have now reached $138.28 million.
The firm has a total of 35 workers. Let’s measure their productivity. In terms of profitability, gross margin is 74.8%, operating margin of -1501.0%, and the pretax margin is -1292.88%.
Compass Therapeutics Inc (CMPX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Compass Therapeutics Inc is 36.70%, while institutional ownership is 43.19%. The most recent insider transaction that took place on Apr 09 ’25, was worth 5,678,571. In this transaction Director of this company sold 3,571,428 shares at a rate of $1.59, taking the stock ownership to the 0 shares. Before that another transaction happened on Apr 09 ’25, when Company’s Director sold 3,571,428 for $1.59, making the entire transaction worth $5,678,571. This insider now owns 0 shares in total.
Compass Therapeutics Inc (CMPX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -38.89% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.27% during the next five years compared to -104.70% drop over the previous five years of trading.
Compass Therapeutics Inc (NASDAQ: CMPX) Trading Performance Indicators
Here are Compass Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 341.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.40, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of Compass Therapeutics Inc (CMPX)
Analysing the last 5-days average volume posted by the [Compass Therapeutics Inc, CMPX], we can find that recorded value of 1.07 million was lower than the volume posted last year of 1.73 million. As of the previous 9 days, the stock’s Stochastic %D was 86.71%. Additionally, its Average True Range was 0.17.
During the past 100 days, Compass Therapeutics Inc’s (CMPX) raw stochastic average was set at 28.00%, which indicates a significant decrease from 93.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.64% in the past 14 days, which was lower than the 117.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.99, while its 200-day Moving Average is $1.93. Now, the first resistance to watch is $2.15. This is followed by the second major resistance level at $2.20. The third major resistance level sits at $2.28. If the price goes on to break the first support level at $2.02, it is likely to go to the next support level at $1.95. Should the price break the second support level, the third support level stands at $1.90.
Compass Therapeutics Inc (NASDAQ: CMPX) Key Stats
With a market capitalization of 290.39 million, the company has a total of 138,283K Shares Outstanding. Currently, annual sales are 850 K while annual income is -49,380 K. The company’s previous quarter sales were 0 K while its latest quarter income was -16,630 K.
